Clinical trials show progress in migraine frequency, skin cancer prevention

-
1:37
Maxwell Anderson’s sentencing date moved; hearing in civil...
-
1:59
Hundreds of School of Rock students tune up before performing...
-
2:35
Summerfest and Juneteenth join forces for historic day of celebration...
-
1:06
CBS 58 General Manager Anne Brown honored with Women of Influence...
-
5:57
Chief Norman discusses recent trend of violence in Milwaukee,...
-
1:58
Dashcam video shows wrong-way driver that killed Oostburg couple
-
2:06
Color of the sky
-
1:35
Local leaders raise Juneteenth flag over Milwaukee City Hall
-
4:41
$4 grilled cheese and milkshake combo returns to popular Watertown...
-
2:44
A break from the heat but storms continue
-
4:19
Milwaukee LGBT Community Center discusses services and support...
-
4:38
Best Buddies conference to focus on inclusion and leadership...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.